| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
(Circulation. 1995;91:566-579.)
© 1995 American Heart Association, Inc.
Articles |
Background and Purpose Indications for carotid endarterectomy have engendered considerable debate among experts and have resulted in publication of retrospective reviews, natural history studies, audits of community practice, position papers, expert opinion statements, and finally prospective randomized trials. The American Heart Association assembled a group of experts in a multidisciplinary consensus conference to develop this statement.
Methods A conference was held July 16-18, 1993, in Park City, Utah, that included recognized experts in neurology, neurosurgery, vascular surgery, and healthcare planning. A program of critical topics was developed, and each expert presented a talk and provided the chairman with a summary statement. From these summary statements a document was developed and edited onsite to achieve consensus before final revision.
Results The first section of this document reviews the natural history, methods of patient evaluation, options for medical management, results of surgical management, data from position statements, and results to date of prospective randomized trials for symptomatic and asymptomatic patients with carotid artery disease. The second section divides 96 potential indications for carotid endarterectomy, based on surgical risk, into four categories: (1) Proven: This is the strongest indication for carotid endarterectomy; data are supported by results of prospective contemporary randomized trials. (2) Acceptable but not proven: a good indication for operation; supported by promising but not scientifically certain data. (3) Uncertain: Data are insufficient to define the risk/benefit ratio. (4) Proven inappropriate: Current data are adequate to show that the risk of surgery outweighs any benefit.
Conclusions Indications for carotid endarterectomy in symptomatic
good-risk patients with a surgeon whose surgical morbidity and
mortality rate is less than 6% are as follows. (1) Proven:
one or more TIAs in the past 6 months and carotid stenosis
70% or mild stroke within 6 months and a carotid stenosis
70%; (2) acceptable but not proven: TIAs
within the past 6 months and a stenosis 50% to 69%, progressive
stroke and a stenosis
70%, mild or moderate stroke in the
past 6 months and a stenosis 50% to 69%, or carotid endarterectomy
ipsilateral to TIAs and a stenosis
70% combined with
required coronary artery bypass grafting; (3) uncertain:
TIAs with a stenosis <50%, mild stroke and stenosis <50%, TIAs with
a stenosis <70% combined with coronary artery bypass grafting, or
symptomatic, acute carotid thrombosis; (4) proven
inappropriate: moderate stroke with stenosis <50%, not on
aspirin; single TIA, <50% stenosis, not on aspirin; high-risk patient
with multiple TIAs, not on aspirin, stenosis <50%; high-risk patient,
mild or moderate stroke, stenosis <50%, not on aspirin; global
ischemic symptoms with stenosis <50%; acute dissection, asymptomatic
on heparin. Indications for carotid endarterectomy in asymptomatic
good-risk patients performed by a surgeon whose surgical morbidity and
mortality rate is less than 3% are as follows. (1) Proven:
none. As this statement went to press, the National Institute of
Neurological Disorders and Stroke issued a clinical advisory stating
that the Institute has halted the Asymptomatic Carotid Atherosclerosis
Study (ACAS) because of a clear benefit in favor of surgery for
patients with carotid stenosis
60% as measured by diameter
reduction. When the ACAS report is published, this indication will
be recategorized as proven. (2) acceptable but not
proven: stenosis >75% by linear diameter; (3)
uncertain: stenosis >75% in a high-risk patient/surgeon
(surgical morbidity and mortality rate >3%), combined
carotid/coronary operations, or ulcerative lesions without
hemodynamically significant stenosis; (4) proven
inappropriate: operations with a combined stroke morbidity and
mortality >5%.
Key Words: carotid endarterectomy stroke clinical trials consensus statement surgery
This article has been cited by other articles:
![]() |
T. Saam, H. R. Underhill, B. Chu, N. Takaya, J. Cai, N. L. Polissar, C. Yuan, and T. S. Hatsukami Prevalence of American Heart Association type VI carotid atherosclerotic lesions identified by magnetic resonance imaging for different levels of stenosis as measured by duplex ultrasound. J. Am. Coll. Cardiol., March 11, 2008; 51(10): 1014 - 1021. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Saba, G. Caddeo, R. Sanfilippo, R. Montisci, and G. Mallarini CT and Ultrasound in the Study of Ulcerated Carotid Plaque Compared with Surgical Results: Potentialities and Advantages of Multidetector Row CT Angiography AJNR Am. J. Neuroradiol., June 1, 2007; 28(6): 1061 - 1066. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. Shrivastava, S. Sookhoo, S. MacDonald, and J. Dunning Is carotid artery stenting equivalent or superior to carotid endarterectomy for treatment of carotid artery stenosis? Interactive CardioVascular and Thoracic Surgery, December 1, 2005; 4(6): 550 - 554. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. J. Alberts, R. E. Latchaw, W. R. Selman, T. Shephard, M. N. Hadley, L. M. Brass, W. Koroshetz, J. R. Marler, J. Booss, R. D. Zorowitz, et al. Recommendations for Comprehensive Stroke Centers: A Consensus Statement From the Brain Attack Coalition Stroke, July 1, 2005; 36(7): 1597 - 1616. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. W G Carrell and J. H N Wolfe Non-cardiac vascular disease Heart, February 1, 2005; 91(2): 265 - 270. [Full Text] [PDF] |
||||
![]() |
S. C. Goehde, P. Hunold, F. M. Vogt, W. Ajaj, M. Goyen, C. U. Herborn, M. Forsting, J. F. Debatin, and S. G. Ruehm Full-Body Cardiovascular and Tumor MRI for Early Detection of Disease: Feasibility and Initial Experience in 298 Subjects Am. J. Roentgenol., February 1, 2005; 184(2): 598 - 611. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Sacks and J. J. Connors III Carotid Stent Placement, Stroke Prevention, and Training Radiology, January 1, 2005; 234(1): 49 - 52. [Full Text] [PDF] |
||||
![]() |
H. E. Rodriguez and L. Leon Current Status of Carotid Angioplasty and Stenting Perspectives in Vascular Surgery and Endovascular Therapy, June 1, 2004; 16(2): 111 - 119. [Abstract] [PDF] |
||||
![]() |
P. H. Lin, R. L. Bush, and A. B. Lumsden Carotid Artery Stenting: Current Status and Future Directions Vascular and Endovascular Surgery, September 1, 2003; 37(5): 315 - 322. [Abstract] [PDF] |
||||
![]() |
K. Sheikh and C. Bullock Sex differences in carotid endarterectomy utilization and 30-day postoperative mortality Neurology, February 11, 2003; 60(3): 471 - 476. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Ghilardi, M. L. Biondi, M. DeMonti, M. Bernini, O. Turri, F. Massaro, E. Guagnellini, and R. Scorza Independent Risk Factor for Moderate to Severe Internal Carotid Artery Stenosis: T786C Mutation of the Endothelial Nitric Oxide Synthase Gene Clin. Chem., July 1, 2002; 48(7): 989 - 993. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. L. Whitlow, P. Lylyk, H. Londero, O. A. Mendiz, K. Mathias, H. Jaeger, J. Parodi, C. Schonholz, and J. Milei Carotid Artery Stenting Protected With an Emboli Containment System Stroke, May 1, 2002; 33(5): 1308 - 1314. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. T. Granton and A. W. Gelb Neuroprotection During Carotid Endarterectomy Seminars in Cardiothoracic and Vascular Anesthesia, March 1, 2002; 6(1): 21 - 25. [Abstract] [PDF] |
||||
![]() |
R. L. Sacco Extracranial Carotid Stenosis N. Engl. J. Med., October 11, 2001; 345(15): 1113 - 1118. [Full Text] [PDF] |
||||
![]() |
Z. Mallat, A. Corbaz, A. Scoazec, S. Besnard, G. Leseche, Y. Chvatchko, and A. Tedgui Expression of Interleukin-18 in Human Atherosclerotic Plaques and Relation to Plaque Instability Circulation, October 2, 2001; 104(14): 1598 - 1603. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Melissano, R. Castellano, R. Zucca, and R. Chiesa Results of Carotid Endarterectomy Performed with Preoperative Duplex Ultrasound Assessment Alone Vascular and Endovascular Surgery, March 1, 2001; 35(2): 95 - 101. [Abstract] [PDF] |
||||
![]() |
B. L. KASISKE, M. A. VAZQUEZ, W. E. HARMON, R. S. BROWN, G. M. DANOVITCH, R. S. GASTON, D. ROTH, J. D. SCANDLING JR., and G. G. SINGER Recommendations for the Outpatient Surveillance of Renal Transplant Recipients J. Am. Soc. Nephrol., October 1, 2000; 11(2007): S1 - S86. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Mauriello, G. Sangiorgi, G. Palmieri, R. Virmani, D. R. Holmes Jr, R. S. Schwartz, R. Pistolese, A. Ippoliti, and L. G. Spagnoli Hyperfibrinogenemia Is Associated With Specific Histocytological Composition and Complications of Atherosclerotic Carotid Plaques in Patients Affected by Transient Ischemic Attacks Circulation, February 22, 2000; 101(7): 744 - 750. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Bell Carotid angioplasty - does it have a place? Vascular Medicine, November 1, 1999; 4(4): 207 - 209. [PDF] |
||||
![]() |
T. A. Manolio, G. L. Burke, D. H. O'Leary, G. Evans, N. Beauchamp, L. Knepper, and B. Ward Relationships of Cerebral MRI Findings to Ultrasonographic Carotid Atherosclerosis in Older Adults : The Cardiovascular Health Study Arterioscler. Thromb. Vasc. Biol., February 1, 1999; 19(2): 356 - 365. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. G. Beebe and B. Kritpracha Surgery for Acute Stroke: Current Status Perspectives in Vascular Surgery and Endovascular Therapy, January 1, 1999; 10(1): 85 - 93. [Abstract] [PDF] |
||||
![]() |
D. M. Kent, S. Chaturvedi, R. D. Cebul, R. J. Snow, R. Pine, N. R. Hertzer, D. E. Wennberg, F. L. Lucas, J. D. Birkmeyer, and E. S. Fisher Outcomes After Carotid Endarterectomy JAMA, October 14, 1998; 280(14): 1228 - 1229. [Full Text] [PDF] |
||||
![]() |
T. S. Huber, K. G. Wheeler, J. K. Cuddeback, D. A. Dame, T. C. Flynn, and J. M. Seeger Effect of the Asymptomatic Carotid Atherosclerosis Study on Carotid Endarterectomy in Florida Stroke, June 1, 1998; 29(6): 1099 - 1105. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. D. Cebul, R. J. Snow, R. Pine, N. R. Hertzer, and D. G. Norris Indications, Outcomes, and Provider Volumes for Carotid Endarterectomy JAMA, April 22, 1998; 279(16): 1282 - 1287. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Biller, W. M. Feinberg, J. E. Castaldo, A. D. Whittemore, R. E. Harbaugh, R. J. Dempsey, L. R. Caplan, T. F. Kresowik, D. B. Matchar, J. F. Toole, et al. Guidelines for Carotid Endarterectomy : A Statement for Healthcare Professionals From a Special Writing Group of the Stroke Council, American Heart Association Circulation, February 10, 1998; 97(5): 501 - 509. [Full Text] [PDF] |
||||
![]() |
F. Masuhr, M. Busch, and K. M. Einhaupl Differences in Medical and Surgical Therapy for Stroke Prevention Between Leading Experts in North America and Western Europe Stroke, February 1, 1998; 29(2): 339 - 345. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Biller, W. M. Feinberg, J. E. Castaldo, A. D. Whittemore, R. E. Harbaugh, R. J. Dempsey, L. R. Caplan, T. F. Kresowik, D. B. Matchar, J. F. Toole, et al. Guidelines for Carotid Endarterectomy : A Statement for Healthcare Professionals From a Special Writing Group of the Stroke Council, American Heart Association Stroke, February 1, 1998; 29(2): 554 - 562. [Full Text] [PDF] |
||||
![]() |
H. R. Karp, W. D. Flanders, C. C. Shipp, B. Taylor, and D. Martin Carotid Endarterectomy Among Medicare Beneficiaries : A Statewide Evaluation of Appropriateness and Outcome Stroke, January 1, 1998; 29(1): 46 - 52. [Abstract] [Full Text] [PDF] |
||||
![]() |
HEART ASSOCIATION ISSUES CAROTID ENDARTERECTOMY.GUIDELINES Journal Watch (General), January 27, 1995; 1995(127): 1 - 1. [Full Text] |
||||
|
Circulation Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 1995 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |